Clinical Trials Logo

Weight clinical trials

View clinical trials related to Weight.

Filter by:

NCT ID: NCT01501994 Completed - Weight Clinical Trials

Personalized Approach for Promoting Physical Activity in Mayo Clinic Physicians

Start date: July 2009
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if providing physicians with a walking workstation, exercise counseling, and accelerometer feedback about activity will increase physician activity.

NCT ID: NCT01440894 Completed - Body Fat Disorder Clinical Trials

Clinical Trail of Transtek Glass Body Fat Analyzer

GBFA
Start date: February 2011
Phase: N/A
Study type: Observational

The clinical protocol of the clinical testing of this device: 1. Objective of the test: To verify the functions and efficiency of devices. 2. Test methods and procedures: Comparison Test. 3. DUT(Device Under Test): Transtek Glass Body Fat Analyzer, Model: GBF-733-W1, GBF-1012, BF-1039, BF-1041-A, and GBF-950-D. 4. Comparison device: Transtek Glass Body Analyzer, GBF-950 (Predicate Device). 5. Study endpoints: Transtek devices and the predicate device are substantial equivalence. 6. Statistical methodology used: Description of statistical methods. 7. Result: Efficiencies of Transtek devices and predicate device are in the same level.

NCT ID: NCT01342471 Completed - Physical Activity Clinical Trials

Physical Activity and Leisure-time Study (PALS)

PALS
Start date: September 2010
Phase: Phase 1
Study type: Interventional

Physical inactivity is a major public health problem and a primary contributing factor to the obesity epidemic. While most Americans do not meet the physical activity (PA) guidelines (30 min/day, 5 day/wk), they do report watching several hours of TV each day, and frequently site "lack of time" as a barrier for engaging in PA. The Physical Activity and Leisure-time Study examines an approach convert sedentary TV watching into active TV watching time by having adults step in place during commercials (TV commercial stepping).

NCT ID: NCT01296048 Completed - Body Fat Disorder Clinical Trials

Clinical Test for Transtek Glass Body Analyzer

GBA
Start date: November 2010
Phase: N/A
Study type: Observational

The clinical protocol of the clinical testing of this device: 1. Objective of the test: To verify the functions and efficiency of devices. 2. Test methods and procedures: Comparison Test. 3. DUT: Transtek Glass Body Analyzer, Model: GBF-830, GBF-835, GBF-950, and SA-15. 4. Comparison device: Scaleman Body Fat Scales, FS-148BW1 (Predicate Device). 5. Study endpoints: Transtek devices and the predicate device are substantial equivalence. 6. Statistical methodology used: Description of statistical methods. 7. Result: Efficiencies of Transtek devices and predicate device are in the same level.

NCT ID: NCT01253876 Completed - Weight Clinical Trials

Effect of Soymilk Replacement on Anthropometric and Blood Pressure Value

Start date: March 2010
Phase: Phase 4
Study type: Interventional

Soymilk components such as isoflavones, essential fatty acids, phytoesterols, good fats, inositols might have beneficial effects on weight control and blood pressure management. Most studies in this regard have been conducted on postmenopausal or premenopausal women and there are few studies on female youths. Therefore, we are going to determine the effects of soy consumption on the weight, waist circumference and blood pressure in overweight and obese female youths. This was a cross-over randomized clinical trial which was conducted in 2010 in Isfahan on overweight or obese young female youths. After three weeks run-in, females were randomly assigned to consume a diet containing caw's milk or a diet in which only one glass of soy milk was substituted; each one for six weeks. Random sequencing generated in SPSS was used for allocating females in different group randomly. Patients were not blinded because they had to use soy milk in one period of trial and use caw's milk in another period.

NCT ID: NCT01180465 Completed - Weight Clinical Trials

A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity

Start date: April 2010
Phase: Phase 2
Study type: Interventional

LIPO-102 is under evaluation for treatment of abdominal adiposity

NCT ID: NCT00999297 Completed - Obesity Clinical Trials

Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate

CAPSPAL
Start date: July 2008
Phase: N/A
Study type: Interventional

A 4 week intake of drug to find a natural substance that may modify energy balance and may enhance health in combination with lifestyle changes with possible decrease in body weight.

NCT ID: NCT00769509 Completed - Weight Clinical Trials

Energy Expenditure Assessment of Premature Infants

Start date: March 2009
Phase: Phase 4
Study type: Interventional

The goal of this study is verify if the energy expenditure in preterm infant fed with human milk is different from preterm formula. A randomized, controlled, crossover, double blind clinical trial will be carried out in which the newborn will be its own control. Randomization will be according to the type of diet at the beginning of the study. Half of the participants will be randomly assigned to begin the study using one type of milk (for example, human milk) and later another type of milk (preterm infant formula) and the other half will do the opposite.